EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Yangxin Tongluo Decoction Protects Against Sepsis‐Associated Cardiac Dysfunction Through Regulating Nrf2 Pathway

Hainan Yang iD, Beijing Wu iD, Die Huang iD, Hui Ye iD, Weifang Yuan iD, Lijiao You iD, Xueru Huang iD, Haikuo Wang iD, Yaoguo Han iD, Ming Lei iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/2804249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 23.07.2026. Verfasst von Hainan Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Datong Road Pudong New Di…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Sepsis, NF-E2-Related Factor 2. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Program of Shanghai Pudong New Area Health Commission, National Traditional Chinese Medicine Advantageous Specialty Construction, Research on Standardized Integrated Chinese and Western Medicine Diagnosis and Treatment Protocols for Electrochemical Thermal Injury.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis‐induced cardiac dysfunction is a major cause of high mortality in critically ill patients. Yangxin Tongluo decoction (YXTLD), a traditional Chinese medicine (TCM) formula, is clinically used for such conditions, but its therapeutic effects and underlying mechanisms remain unclear. This study investigated the protective role of YXTLD against sepsis‐associated cardiac dysfunction and its relationship with the Nrf2 signaling pathway.

Methods

An in vivo model of sepsis was established in male C57BL/6 mice via intraperitoneal lipopolysaccharide (LPS) injection. Cardiac function was assessed by echocardiography and serum biomarkers (creatine kinase [CK], lactate dehydrogenase [LDH]). In vitro, LPS‐stimulated H9c2 cardiomyocytes were treated with various doses of YXTLD. Cell viability, inflammation (interleukin [IL]‐1β, IL‐6, TNF‐α), oxidative stress (reactive oxygen species [ROS], malondialdehyde [MDA], catalase [CAT], glutathione [GSH]), and apoptosis were evaluated. The involvement of the Nrf2 pathway was examined using western blotting. In vivo dosage: YXTLD was administered intraperitoneally five times prior to LPS induction and continued after induction (total of seven doses over 48 h). In vitro concentrations: low (50 μg/mL), medium (100 μg/mL), and high (150 μg/mL) YXTLD.

Results

YXTLD significantly improved cardiac function and alleviated myocardial injury in septic mice, as evidenced by increased ejection fraction (EF; 97.87% ± 1.20% vs. 79.05% ± 3.04%) and fractional shortening (FS; 74.99% ± 5.58% vs. 41.98% ± 2.72%), together with reduced serum CK (188.60 ± 81.16 vs. 566.75 ± 186.24 U/L) and LDH (179.70 ± 54.47 vs. 463.65 ± 197.58 U/L) levels compared with the LPS group (all p < 0.05). In LPS‐stimulated H9c2 cells, YXTLD dose‐dependently enhanced cell viability, suppressed the expression of pro‐inflammatory cytokines (IL‐6, IL‐1β, and TNF‐α), reduced ROS production and lipid peroxidation, restored antioxidant capacity, and inhibited apoptosis. At 50 μg/mL, YXTLD markedly decreased IL‐6, IL‐1β, and TNF‐α levels by ~78%, 63%, and 92%, respectively (all p < 0.05). ROS and apoptotic cell proportions were progressively reduced with increasing YXTLD concentrations, reaching reductions of ~82% and 95%, respectively, at 150 μg/mL ( p < 0.001). Mechanistically, YXTLD activated the Nrf2 signaling pathway by promoting nuclear Nrf2 translocation and upregulating its downstream antioxidant proteins, including heme oxygenase‐1 (HO‐1), NAD(P)H quinone dehydrogenase 1 (NQO1), and glutamate‐cysteine ligase modifier (GCLM). YXTLD also restored CAT and GSH levels while reducing MDA accumulation, indicating attenuation of oxidative stress.

Conclusion

YXTLD protects against sepsis‐induced cardiac dysfunction by attenuating inflammation, oxidative stress, and apoptosis through activation of the Nrf2 signaling pathway. These findings provide a pharmacological basis for YXTLD as a potential therapeutic strategy for sepsis‐associated cardiac dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalSepsisNF-E2-Related Factor 2AnimalsMiceMaleMice, Inbred C57BLOxidative StressSignal TransductionApoptosisLipopolysaccharidesMyocytes, CardiacReactive Oxygen SpeciesCell LineCell SurvivalRatsInterleukin-6Malondialdehyde

Stichwörter der Autor:innen

Nrf2 pathwayYangxin Tongluo decoctionapoptosiscardiac dysfunctionoxidative stresssepsis

Substanzen

Drugs, Chinese HerbalNF-E2-Related Factor 2LipopolysaccharidestongxinluoReactive Oxygen SpeciesNfe2l2 protein, mouseInterleukin-6Malondialdehyde

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Datong Road Pudong New District, Shanghai 200137, China, shutcm.edu.cn.
  • Department of Rehabilitation, Liuzao Community Health Service Center, Pudong New District, Shanghai 201322, China.
  • Department of General Practice, Beicai Community Health Service Center, Pudong New District, Shanghai 201204, China.

ORCID-Profile: Hainan Yang, Beijing Wu, Die Huang, Hui Ye, Weifang Yuan, Lijiao You, Xueru Huang, Haikuo Wang, Yaoguo Han, Ming Lei

Förderung

  • Scientific Research Program of Shanghai Pudong New Area Health Commission
  • National Traditional Chinese Medicine Advantageous Specialty Construction
  • Research on Standardized Integrated Chinese and Western Medicine Diagnosis and Treatment Protocols for Electrochemical Thermal Injury
  • Clinical Emergency Medicine Center Project of Shanghai Seventh People's Hospital

Zitieren

APA

Yang, H., Wu, B., Huang, D., Ye, H., Yuan, W., You, L., Huang, X., Wang, H., Han, Y., & Lei, M. (2026). Yangxin Tongluo Decoction Protects Against Sepsis‐Associated Cardiac Dysfunction Through Regulating Nrf2 Pathway. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/2804249

Vancouver

Yang H, Wu B, Huang D, Ye H, Yuan W, You L, et al. Yangxin Tongluo Decoction Protects Against Sepsis‐Associated Cardiac Dysfunction Through Regulating Nrf2 Pathway. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/2804249

BibTeX
@article{Yang2026,
  author = {Yang, Hainan and Wu, Beijing and Huang, Die and Ye, Hui and Yuan, Weifang and You, Lijiao and Huang, Xueru and Wang, Haikuo and Han, Yaoguo and Lei, Ming},
  title = {Yangxin Tongluo Decoction Protects Against Sepsis‐Associated Cardiac Dysfunction Through Regulating Nrf2 Pathway},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/2804249}
}
Kostenlos starten →